Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-004180
Filing Date
2015-01-14
Accepted
2015-01-14 16:06:09
Documents
2
Period of Report
2015-01-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5683
2 POA DOCUMENT poa.txt EX-24.4_554846 6348
  Complete submission text file 0001209191-15-004180.txt   13430
Mailing Address 3000 SAND HILL RD, BLDG 1, STE 135 C/O DELPHI VENTURES MENLO PARK CA 94025
Business Address
PAKIANATHAN DEEPIKA (Reporting) CIK: 0001270734 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 15527303

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations